Human bone marrow stem cells; available from the Inbiobank stem cell bank.
Inbiobank is a non-profit organisation, set up by the medical charity, the Inbiomed Foundation, with a brief to generate and characterise stem cells suitable for use in both basic and clinical research.
The bank’s cell production plant has ISO 9001- 2000 quality certification and operates with GMP (Good Manufacturing Practices) conditions, thus guaranteeing the clinical quality of the cells produced. The facility is authorised by the Spanish Medicines Agency to carry out clinical trials in somatic cell therapy, only the second in Spain to get such a licence.
Currently, Inbiomed is working on three main lines of basic research, all based on the study of human adult stem cells from bone marrow, umbilical cord, adipose, skin and neuronal tissue.
Researchers are studying the genetic and biochemical mechanisms that are involved in the multiplication and differentiation of these cells in the various body tissues, and their biological function. The overall aim is to create an in vitro the environment in which adult stem cells can be persuaded multiply and differentiate along specific pathways.
On the clinical side, the Inbiomed Foundation is collaborating with the Spanish Consortium for Epidermolisis Bullosa in clinical trials to test the efficacy and safety of a new treatment for the skin disease, based on engineered chimeric bi-laminar skin grown in a laboratory.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
